Emerging resistance among bacterial pathogens in the intensive care unit – a European and North American Surveillance study (2000–2002)

Similar Items

• Activity of ceftriaxone and comparator agents against bacterial pathogens isolated from central nervous system (CNS) (meningeal) specimens: TSN Database USA 2000–2002
  od: Jones, ME, i dr.
  Izdano: (2003)
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  od: Wenzel, Richard P., i dr.
  Izdano: (2003)
• Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002
  od: Karlowsky, James A, i dr.
  Izdano: (2004)
• Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of <it>Streptococcus pneumoniae </it>by clinical laboratories in the United States during 2002 and 2003
  od: Thornsberry Clyde, i dr.
  Izdano: (2004-01-01)
• Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003
  od: Master, Ronald N, i dr.
  Izdano: (2004)